Olympus will distribute Bard's GI (gastrointestinal) products:
This article was originally published in Clinica
CR Bard has formed exclusive agreements with Olympus Europe and KeyMed for the distribution of its disposable gastrointestinal and endoscopic accessories for gastroenterological procedures in Europe, the Middle East and Africa. The two companies are wholly-owned subsidiaries of Olympus Optical. Bard's endoscopic feeding devices are not covered by the agreement and will continue to be distributed by Bard.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.